Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Society HCM City keeps eye on facilities, says will not allow number of COVID-19 cases to rise beyond 300